C3 glomerulopathy: consensus report
Top Cited Papers
Open Access
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 84 (6), 1079-1089
- https://doi.org/10.1038/ki.2013.377
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulationJCI Insight, 2013
- Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulationKidney International, 2012
- A Hybrid CFHR3-1 Gene Causes Familial C3 GlomerulopathyJournal of the American Society of Nephrology, 2012
- Eculizumab for Dense Deposit Disease and C3 GlomerulonephritisClinical Journal of the American Society of Nephrology, 2012
- Allelic Variants of Complement Genes Associated with Dense Deposit DiseaseJournal of the American Society of Nephrology, 2011
- Familial C3 Glomerulopathy Associated with CFHR5 MutationsClinical Journal of the American Society of Nephrology, 2011
- Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationJCI Insight, 2010
- Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisThe Lancet, 2010
- Membranoproliferative Glomerulonephritis Secondary to Monoclonal GammopathyClinical Journal of the American Society of Nephrology, 2010
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences of the United States of America, 2006